Stock listing

Keymed Biosciences, Inc.

Selected listing: 2162 · HKEX · HKD · HK

Keymed Biosciences, Inc. (HKEX:2162), Health Technology. Latest release Aug 20, 2026: Keymed Biosciences Announces 2026 H1 Results and Business Updates.

2162:HKEXHKDHKUpdated September 25, 2026

Ticker: HKEX:2162
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: HKEX
Currency: HKD

About Keymed Biosciences, Inc.

Keymed Biosciences, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 2162. Keymed focuses on developing innovative therapies and solutions in the biotechnology sector.

Latest news from Keymed Biosciences, Inc.

Keymed Biosciences Announces 2026 H1 Results and Business Updates

August 20, 2026

Keymed Biosciences Announces 2025 Annual Results and Business Updates

March 26, 2026

Keymed Biosciences (02162.HK) Reports Strong Interim 2025 Results with Accelerated Commercialization and Robust R&D Momentum

August 27, 2025

Keymed Biosciences Announces The Latest Clinical Trial Results Of Cm336 Published In The New England Journal Of Medicine

June 16, 2025

Keymed Biosciences Announces the Latest Clinical Trial Results of CM336 Published in the New England Journal of Medicine

June 11, 2025

All Keymed Biosciences, Inc. news →

Research Keymed Biosciences, Inc.

Keymed Biosciences, Inc. company profile

View the public company page for Keymed Biosciences, Inc. on 6ix.

Keymed Biosciences, Inc. news

Read company news and market updates connected to Keymed Biosciences, Inc..

Keymed Biosciences, Inc. investor events

Find investor webinars, events, and replay context for Keymed Biosciences, Inc..